MSB 4.69% $1.45 mesoblast limited

CEO Itescu needs to go, page-182

  1. 17,088 Posts.
    lightbulb Created with Sketch. 2416
    Well Mesoblast is claiming that potency has increased because of their new manufacturing process. Which really underlies why the FDA want to see a new trial, because previously effiacy wasn't demonstrated. "Trust me, it works" isn't sufficient evidence for the FDA, no matter who says it.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.